Luis A. Clavell

6.0k citations
61 papers · 3.9k · h-index 28

Impact in

Papers in

Co-authors
Stephen E. Sallan (47 shared papers)Marshall A. Schorin (36 shared papers)Lewis B. Silverman (39 shared papers)Barbara L. Asselin (29 shared papers)Harvey J. Cohen (12 shared papers)Donna Neuberg (26 shared papers)Steven E. Lipshultz (14 shared papers)Richard D. Gelber (12 shared papers)
Journals
Journal of Clinical Oncology (10 papers)Blood (10 papers)Cancer (6 papers)Pediatric Blood & Cancer (5 papers)New England Journal of Medicine (2 papers)
Partner nations
United StatesCanadaPuerto Rico

In The Last Decade

Luis A. Clavell

61 papers receiving 3.8k citations

Peers

Luis A. Clavell
Comparison fields: 5 of 99
  • Pediatrics, Perinatology and Child Health 1.2k
  • Cardiology and Cardiovascular Medicine 1.3k
  • Public Health, Environmental and Occupational Health 1.6k
  • Hematology 623
  • Speech and Hearing 217
Replace Laurel J. Steinherz with:
Laurel J. Steinherz United States
Brigid G. Leventhal United States
Colin G. Steward United Kingdom
Lynette D. Fairbanks United Kingdom
Arnold I. Freeman United States
Ajay Vora United Kingdom
Anne Angiolillo United States
Frederick G. Behm United States
Chiara Messina Italy
Dirk Schwabe Germany
Luis A. Clavell relative to Laurel J. Steinherz United States Laurel J. Steinherz's profile →
Citations per field
00.5×10×20×31×
Laurel J. Steinherz · 1×
Citations per year

Countries citing papers authored by Luis A. Clavell

Since Specialization
Citations

This map shows the geographic impact of Luis A. Clavell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis A. Clavell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis A. Clavell more than expected).

Fields of papers citing papers by Luis A. Clavell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis A. Clavell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis A. Clavell. The network helps show where Luis A. Clavell may publish in the future.

Co-authors

The 25 scholars most cited alongside Luis A. Clavell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luis A. Clavell Line = papers co-authored together Luis A. Clavell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia
New England Journal of Medicine ·Steven E. Lipshultz, Nader Rifai, Virginia Dalton, Donna E. Levy, Lewis B. Silverman, Stuart R. Lipsitz, Steven D. Colan, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Richard D. Gelber, Stephen E. Sallan
2004424
2
Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia
New England Journal of Medicine ·Luis A. Clavell, Richard D. Gelber, Harvey J. Cohen, Suzanne Hitchcock‐Bryan, J. Robert Cassady, Nancy J. Tarbell, S. Blattner, Ramana Tantravahi, Pearl Leavitt, Stephen E. Sallan
1986331
3
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
The Lancet Oncology ·Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz, Stephen E. Sallan, Lewis B. Silverman, Tracie L. Miller, Elly Barry, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Eric Larsen, Albert Moghrabi, Yvan Samson, Bruno Michon, Marshall A. Schorin, Harvey J. Cohen, Donna Neuberg, E. John Orav, Steven D. Colan
2010320
4
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
Blood ·Albert Moghrabi, Donna E. Levy, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Yvan Samson, Marshall A. Schorin, Virginia Kimball Dalton, Steven E. Lipshultz, Donna Neuberg, Richard D. Gelber, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman
2006311
5
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
Leukemia ·Lewis B. Silverman, Kristen E. Stevenson, Jane E. O’Brien, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Claire Schwartz, Eileen W. O’Holleran, Donna Neuberg, Harvey J. Cohen, Stephen E. Sallan
2009232
6
Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
Journal of Clinical Oncology ·Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Jane O’Brien, Suzanne E. Dahlberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Kara M. Kelly, Jeffery L. Kutok, Caroline Laverdière, Steven E. Lipshultz, Bruno Michon, Marshall A. Schorin, Mary V. Relling, Harvey J. Cohen, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman
2013230
7
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
Journal of Clinical Oncology ·Steven E. Lipshultz, Tracie L. Miller, Rebecca E. Scully, Stuart R. Lipsitz, Nader Rifai, Lewis B. Silverman, Steven D. Colan, Donna Neuberg, Suzanne E. Dahlberg, Jacqueline Henkel, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Stephen E. Sallan
2012227
8
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT
The Lancet ·Jerome Ritz, Robert C. Bast, Luis A. Clavell, Thierry Hercend, Stephen E. Sallan, Jeffrey M. Lipton, Maryellen Feeney, David G. Nathan, Stuart F. Schlossman
1982187
9
Favorable Outcome for Adolescents With Acute Lymphoblastic Leukemia Treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Journal of Clinical Oncology ·Elly Barry, Daniel J. DeAngelo, Donna Neuberg, Kristen E. Stevenson, Mignon L. Loh, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman
2007137
10
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia
Pediatric Blood & Cancer ·Lynda M. Vrooman, Jeffrey G. Supko, Donna Neuberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Kara M. Kelly, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman
2009128
11
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia
Cancer ·Steven E. Lipshultz, Stuart R. Lipsitz, Jeffery L. Kutok, Tracie L. Miller, Steven D. Colan, Donna Neuberg, Kristen E. Stevenson, Mark D. Fleming, Stephen E. Sallan, Vivian I. Franco, Jacqueline Henkel, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Bruno Michon, Caroline Laverdière, Eric Larsen, Kara M. Kelly, Lewis B. Silverman
2013117
12
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
PEDIATRICS ·Steven E. Lipshultz, Tracie L. Miller, Stuart R. Lipsitz, Donna Neuberg, Suzanne E. Dahlberg, Steven D. Colan, Lewis B. Silverman, Jacqueline Henkel, Vivian I. Franco, Laura L. Cushman, Barbara L. Asselin, Luis A. Clavell, Uma H. Athale, Bruno Michon, Caroline Laverdière, Marshall A. Schorin, Eric Larsen, Naheed Usmani, Stephen E. Sallan
2012108
13
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia
Cancer ·Craig A. Hurwitz, Lewis B. Silverman, Marshall A. Schorin, Luis A. Clavell, Virginia Kimball Dalton, Kathleen M. Glick, Richard D. Gelber, Stephen E. Sallan
200099
14
Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol
Journal of Clinical Oncology ·Steven E. Lipshultz, Amy Giantris, Stuart R. Lipsitz, Virginia Kimball Dalton, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Richard D. Gelber, Stephen E. Sallan, Steven D. Colan
200291
15
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
European Journal of Cancer ·Lynda M. Vrooman, Donna Neuberg, Kristen E. Stevenson, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Eric Larsen, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Cindy L. Schwartz, Harvey J. Cohen, Steven E. Lipshultz, Lewis B. Silverman, Stephen E. Sallan
201190
16
Height and Weight in Children Treated for Acute Lymphoblastic Leukemia: Relationship to CNS Treatment
Journal of Clinical Oncology ·Virginia Kimball Dalton, Montserrat Rué, Lewis B. Silverman, Richard D. Gelber, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Nancy J. Tarbell, Stephen E. Sallan, Laurie E. Cohen
200389
17
Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane
Journal of Clinical Oncology ·Elly Barry, Lynda M. Vrooman, Suzanne E. Dahlberg, Donna Neuberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Eric Larsen, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Harvey J. Cohen, Steven E. Lipshultz, Stephen E. Sallan, Lewis B. Silverman
200889
18
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Blood ·Lewis B. Silverman, Jeffrey G. Supko, Kristen E. Stevenson, Christina Woodward, Lynda M. Vrooman, Donna Neuberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Cindy L. Schwartz, Jane E. O’Brien, Harvey J. Cohen, Stephen E. Sallan
200973
19
Hemolytic Interaction of Newcastle Disease Virus and Chicken Erythrocytes. II. Determining Factors
Applied Microbiology ·Luis A. Clavell, Michael A. Bratt
197248
20
Incidence and Risk Factors for Developing Dengue-Associated Hemophagocytic Lymphohistiocytosis in Puerto Rico, 2008 - 2013
PLoS neglected tropical diseases ·Esther M. Ellis, Tyler M. Sharp, Janice Pérez‐Padilla, González Liza, B. Katherine Poole‐Smith, Emmaculate Lebo, Charlotte Baker, Mark Delorey, Brenda Torres-Velásquez, Ochoa Eduardo, Brenda Rivera-García, Díaz-Pinto Hector, Luis A. Clavell, Anabel Puig-Ramos, Gritta Janka, Kay M. Tomashek
201642

About Luis A. Clavell

Luis A. Clavell is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Cardiology and Cardiovascular Medicine, Hematology and Infectious Diseases, having authored 61 papers that have together received 3.9k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (28 papers), Childhood Cancer Survivors' Quality of Life (14 papers), Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Virology and Viral Diseases (5 papers), Pharmaceutical studies and practices (5 papers), Viral Infections and Vectors (4 papers), Acute Myeloid Leukemia Research (4 papers) and Mosquito-borne diseases and control (4 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (1.2k citations), Cardiology and Cardiovascular Medicine (1.3k citations), Public Health, Environmental and Occupational Health (1.6k citations), Hematology (623 citations) and Speech and Hearing (217 citations). Luis A. Clavell has collaborated with scholars based in United States, Canada and Puerto Rico. Frequent co-authors include Stephen E. Sallan, Marshall A. Schorin, Lewis B. Silverman, Barbara L. Asselin, Harvey J. Cohen, Donna Neuberg, Steven E. Lipshultz, Richard D. Gelber, Bruno Michon and Yvan Samson. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, Pediatric Blood & Cancer and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurel J. SteinherzBreakdown of academic impact, for papers by Brigid G. LeventhalBreakdown of academic impact, for papers by Colin G. StewardBreakdown of academic impact, for papers by Lynette D. FairbanksBreakdown of academic impact, for papers by Arnold I. FreemanBreakdown of academic impact, for papers by Ajay VoraBreakdown of academic impact, for papers by Anne AngiolilloBreakdown of academic impact, for papers by Frederick G. BehmBreakdown of academic impact, for papers by Chiara MessinaBreakdown of academic impact, for papers by Dirk Schwabe